Overview

Bioequivalence Study of Morphine Sulfate 60 mg Extended-Release Tablets Under Fasting Conditions

Status:
Completed
Trial end date:
2006-12-01
Target enrollment:
Participant gender:
Summary
The study was to evaluate the relative bioavailability of morphine and morphine-6-glucuronide from 2 tablet products and determine if the 2 products were bioequivalent to each other.
Phase:
Phase 1
Details
Lead Sponsor:
Ranbaxy Inc.
Treatments:
Morphine